StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens upped their target price on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
Get Our Latest Stock Report on MDRX
Veradigm Trading Up 1.0 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- Using the MarketBeat Stock Split Calculator
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- The Role Economic Reports Play in a Successful Investment Strategy
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
